Scientific and clinical advisory
Mechanism, clinical relevance, evidence, risk, positioning, development strategy, and interpretation of emerging or experimental treatments.
Research and advisory collaboration
Peter R. Feldman, PhD (Medicine), is a hair researcher and Founder and Director of Feldman Hair Institute. His work spans clinical trials, hair-follicle biology, formulation and treatment strategy, clinical measurement, longitudinal imaging, data design, and clinically interpretable AI-assisted models.
Selected collaborations support drugs, cosmetics, supplements, devices, procedures and biologics.
FHI also supports investors, acquirers and strategic partners evaluating hair-loss treatments, technologies, claims, datasets and development programs.
Professional proposition
Translating biological signals into clinically meaningful states and measurable endpoints that support patient benefit and sound development decisions.
Selected collaboration areas
Clinical trials and study design
Feasibility, protocol design, inclusion criteria, comparators, treatment timing, endpoints, photography, trichoscopy, measurement, data collection, interpretation plans, and investigator collaboration.
Formulation and treatment strategy
Oral and topical formulations, combination regimens, procedure-supported approaches, experimental treatments, ingredient rationale, evidence gaps, and development priorities.
Measurement, data, and AI models
Endpoint definitions, longitudinal imaging, annotation frameworks, data architecture, validation plans, model inputs, and clinically interpretable outputs.
Product, claims and scientific due diligence
Assessment of claims, mechanism, existing evidence, gaps, and study priorities.
Clinical training and professional education
Case interpretation, clinical photography, trichoscopy, measurement, treatment-response assessment, lectures, master classes, and professional training programs.
Scientific writing, manuscripts, and review
Evidence synthesis, manuscript development, critical review, journal peer review, and scientific communication.
Research and scientific advisory inquiries
For research and professional inquiries only. Patient records and clinical questions must use Jane or another secure patient pathway specifically provided by FHI.